|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
11/9/17 Lanman Richard B. 4 Director² 1:5K Biolase, Inc. DONNELLEY FIN… File16/FA
11/9/17 Talevich James R 4 Director² 1:5K Biolase, Inc. DONNELLEY FIN… File16/FA
11/9/17 Lord Jonathan T MD 4 Director² 1:5K Biolase, Inc. DONNELLEY FIN… File16/FA
11/9/17 Schuler Jack W SC 13D/A 1:136K Biolase, Inc. Sidley Austin LLP/FA
11/9/17 Feinberg Larry N SC 13D/A 1:214K Biolase, Inc. Willkie Farr & Gallagher
Feinberg Family Foundation³
Oracle Associates, LLC³
Oracle Institutional Partners, LP³
Oracle Investment Management, Inc.³
Oracle Investment Management, Inc. Employees Retirement Plan³
Oracle Partners, L.P.³
Oracle Ten Fund Master, LP³
11/9/17 Biolase, Inc. 424B3 1:407K Donnelley … Solutions/FA
11/9/17 Biolase, Inc. 8-K:1,8,9 11/9/17 4:70K Donnelley … Solutions/FA
11/8/17‡ Biolase, Inc. EFFECT 11/8/17 1:2K SEC #5
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 424B3 | Prospectus – New Facts or Events. | | EFFECT | SEC Notice of Effectiveness. | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|